Despite significant advances in treatment of primary tumors, metastatic cancer remains a leading cause of solid cancer mortality. HiberCell seeks to change that. As “the dormancy company,” they are the first company exclusively focused on therapeutically modulating the biology and mechanisms of tumor dormancy.

Biotechnology

HiberCell

HiberCell's headquarters in New York, NY, United States

Beth Johnson

Michael Danielson

Ari Nowacek

José Iglesias

Eric Lightcap

Haiguo Wu

Kyle Michel

Hui Wang

Nandita Bose

Jeremy Drees

Alexander Conte

Paulette Mattson

Julio Aguirre-Ghiso

Christoph Klein

Cindy Jacobs

Jim Sullivan

Colin Goddard

Lisa M. Coussens

Philip Rowlands

Gregory L. Beatty

Steven Gillis

Ronald Wek

Ruggero De Maria

The Scientific Advisory team at HiberCell provides critical expertise and strategic guidance on the therapeutic modulation of tumor dormancy. Comprised of leading experts, this team advises on research directions, evaluates scientific approaches, and ensures alignment with the latest advancements in oncology to help combat metastatic cancer.

Scientific Advisory

This department focuses on advancing research from the laboratory to clinical applications in oncology and related fields.

Translational Medicine

The Leadership Team at HiberCell is responsible for setting the strategic direction and vision of the company, driving innovation in cancer treatment, and overseeing the development of therapies that target tumor dormancy. Comprising experts in various fields, including pharmacology, clinical operations, and immunology, the team collaborates to ensure effective execution of research initiatives, foster partnerships, and navigate the complexities of bringing novel treatments to market. Their collective expertise guides HiberCell's mission to address the challenges of metastatic cancer and improve patient outcomes.

Leadership Team

The Scientific and Clinical Research team at HiberCell is dedicated to advancing our understanding and treatment of metastatic cancer by focusing on tumor dormancy. They design, conduct, and oversee clinical trials, develop preclinical pharmacology models, and apply bioinformatics to analyze data. This team integrates translational medicine and immunology insights to translate scientific discoveries into therapeutic strategies aimed at modulating tumor dormancy.

Scientific and Clinical Research

This department manages executive support and operational functions to facilitate effective leadership and administrative efficiency.

Administrative Operations

The Directors team at HiberCell provides strategic oversight and guidance, ensuring the company's focus on therapeutically modulating tumor dormancy is effectively executed. They collaborate to drive key decisions, align organizational objectives, and foster innovative approaches to combat metastatic cancer.

HiberCell

Org chart

Board & advisors

Teams

Scientific Advisory

Translational Medicine

Leadership Team

Scientific and Clinical Research

Administrative Operations

Directors

Offices

HiberCell

Org chart

Board & advisors

Teams

Scientific Advisory

Translational Medicine

Leadership Team

Scientific and Clinical Research

Administrative Operations

Directors

Offices

Related companies